Cargando…
Mass-Spectrometry-Based Functional Proteomic and Phosphoproteomic Technologies and Their Application for Analyzing Ex Vivo and In Vitro Models of Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is an autosomal dominant disease thought to be principally caused by mutations in sarcomeric proteins. Despite extensive genetic analysis, there are no comprehensive molecular frameworks for how single mutations in contractile proteins result in the diverse assortme...
Autores principales: | Moore, Jarrod, Emili, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709159/ https://www.ncbi.nlm.nih.gov/pubmed/34948439 http://dx.doi.org/10.3390/ijms222413644 |
Ejemplares similares
-
Proteomic and phosphoproteomic analyses of myectomy tissue reveals difference between sarcomeric and genotype-negative hypertrophic cardiomyopathy
por: Garmany, Ramin, et al.
Publicado: (2023) -
Comprehensive characterization of the adult ND4 Swiss Webster mouse retina: Using discovery-based mass spectrometry to decipher the total proteome and phosphoproteome
por: Harman, Jarrod C., et al.
Publicado: (2018) -
Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AML
por: Gosline, Sara J. C., et al.
Publicado: (2022) -
Functional phosphoproteomic mass spectrometry-based approaches
por: López, Elena, et al.
Publicado: (2012) -
Mass Spectrometry-Based Characterization of the Virion Proteome, Phosphoproteome, and Associated Kinase Activity of Human Cytomegalovirus
por: Couté, Yohann, et al.
Publicado: (2020)